Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

Key Takeaways, With Data for Maryland FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA ...

An innovative treatment based on harmine and alpha cells could transform diabetes treatment and reduce insulin dependence ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...